SCHOLAR ROCK HOLDING CORPORATION Increase (Decrease) in Accrued Liabilities
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Increase (Decrease) in Accrued Liabilities of $14.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $10.22M, a 37.98% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $4.68M.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$10.30M, a 663.35% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $5.74M, a 20.76% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for fiscal 2025 was $8.50M, a 19.31% decline from fiscal 2024.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for fiscal 2024 was $10.53M.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for fiscal 2023 was -$3.93M, a 157.00% decline from fiscal 2022.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in accrued liabilities for fiscal 2022 was $6.89M, a 88.07% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $14.90M 10-Q · filed 2026-08-06 | $4.61M derived: sum of 3 quarters · filed 2026-08-06 | $10.35M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $4.68M 10-Q · filed 2026-05-07 | -$5.61M derived: sum of 2 quarters · filed 2026-05-07 | $130.00K derived: sum of 3 quarters · filed 2026-05-07 | $16.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$4.55M derived: sum of 2 quarters · filed 2026-03-03 | $11.92M derived: sum of 3 quarters · filed 2026-08-06 | $8.50M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $22.22M derived: sum of 2 quarters · filed 2026-08-06 | $18.80M 10-Q · filed 2025-11-14 | $20.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $16.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.05M 10-Q · filed 2026-08-06 | $13.00M 10-Q · filed 2025-08-06 | $14.88M derived: sum of 3 quarters · filed 2026-08-06 | $22.13M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$3.42M 10-Q · filed 2026-05-07 | -$3.45M 10-Q · filed 2025-05-14 | -$1.60M derived: sum of 2 quarters · filed 2026-05-07 | $5.65M derived: sum of 3 quarters · filed 2026-05-07 | $6.14M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.08M derived: sum of 2 quarters · filed 2026-03-03 | $9.57M derived: sum of 3 quarters · filed 2026-03-03 | $10.53M 10-K · filed 2026-03-03 | $10.65M 10-K · filed 2025-02-27 | |||
| 2024-09-30 | $7.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $7.74M derived: sum of 2 quarters · filed 2025-11-14 | $8.71M 10-Q · filed 2025-11-14 | $8.82M 10-Q · filed 2024-11-12 | $11.70M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $493.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.46M 10-Q · filed 2025-08-06 | $4.45M derived: sum of 3 quarters · filed 2025-08-06 | $8.04M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $963.00K 10-Q · filed 2025-05-14 | $3.96M derived: sum of 2 quarters · filed 2025-05-14 | $7.55M derived: sum of 3 quarters · filed 2025-05-14 | $6.63M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.59M derived: sum of 2 quarters · filed 2025-02-27 | $5.66M derived: sum of 3 quarters · filed 2025-02-27 | -$3.93M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.67M derived: sum of 2 quarters · filed 2024-11-12 | -$6.92M 10-Q · filed 2024-11-12 | -$5.36M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$925.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$10.52M 10-Q · filed 2024-08-08 | -$8.95M derived: sum of 3 quarters · filed 2024-08-08 | -$3.64M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$9.59M 10-Q · filed 2024-05-07 | -$8.02M derived: sum of 2 quarters · filed 2024-05-07 | -$2.72M derived: sum of 3 quarters · filed 2024-05-07 | -$1.12M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $6.87M derived: sum of 2 quarters · filed 2024-03-19 | $8.47M derived: sum of 3 quarters · filed 2024-03-19 | $6.89M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $6.90M derived: sum of 2 quarters · filed 2023-11-07 | $5.32M 10-Q · filed 2023-11-07 | $4.87M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $17.00K 10-Q · filed 2023-08-09 | -$440.00K derived: sum of 3 quarters · filed 2023-08-09 | $2.45M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$1.58M 10-Q · filed 2023-05-09 | -$2.04M derived: sum of 2 quarters · filed 2023-05-09 | $857.00K derived: sum of 3 quarters · filed 2023-05-09 | $1.58M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $2.44M derived: sum of 2 quarters · filed 2023-03-07 | $3.16M derived: sum of 3 quarters · filed 2023-03-07 | $3.66M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.61M derived: sum of 2 quarters · filed 2022-11-14 | $4.12M 10-Q · filed 2022-11-14 | $7.34M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $721.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.23M 10-Q · filed 2022-08-08 | $4.45M derived: sum of 3 quarters · filed 2022-08-08 | $7.69M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $506.00K 10-Q · filed 2022-05-16 | $3.73M derived: sum of 2 quarters · filed 2022-05-16 | $6.97M derived: sum of 3 quarters · filed 2022-05-16 | $7.83M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $6.47M derived: sum of 2 quarters · filed 2022-03-07 | $7.32M derived: sum of 3 quarters · filed 2022-03-07 | $5.09M 10-K · filed 2022-03-07 | ||||
| 2020-09-30 | $3.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $4.10M derived: sum of 2 quarters · filed 2021-11-09 | $1.86M 10-Q · filed 2021-11-09 | $3.33M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $857.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$1.38M 10-Q · filed 2021-08-10 | $92.00K derived: sum of 3 quarters · filed 2021-08-10 | $2.85M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$2.23M 10-Q · filed 2021-05-13 | -$765.00K derived: sum of 2 quarters · filed 2021-05-13 | $1.99M derived: sum of 3 quarters · filed 2021-05-13 | $3.23M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $4.22M derived: sum of 2 quarters · filed 2021-03-09 | $5.47M derived: sum of 3 quarters · filed 2021-03-09 | $2.45M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.00M derived: sum of 2 quarters · filed 2020-11-09 | $984.00K 10-Q · filed 2020-11-09 | $4.80M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$1.77M 10-Q · filed 2020-08-07 | $2.05M derived: sum of 3 quarters · filed 2020-08-07 | $2.40M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | -$3.02M 10-Q · filed 2020-05-07 | $802.00K derived: sum of 2 quarters · filed 2020-05-07 | $1.15M derived: sum of 3 quarters · filed 2020-05-07 | $2.62M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $4.17M derived: sum of 2 quarters · filed 2020-03-12 | $5.63M derived: sum of 3 quarters · filed 2020-03-12 | $4.36M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.81M derived: sum of 2 quarters · filed 2019-11-12 | $543.00K 10-Q · filed 2019-11-12 | $2.01M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $191.00K 10-Q · filed 2019-08-14 | $1.66M derived: sum of 3 quarters · filed 2019-08-14 | $1.76M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$1.27M 10-Q · filed 2019-05-15 | $197.00K derived: sum of 2 quarters · filed 2019-05-15 | $295.00K derived: sum of 3 quarters · filed 2019-05-15 | |||||
| 2017-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $1.57M derived: sum of 2 quarters · filed 2019-03-19 | $1.31M 10-K · filed 2019-03-19 | |||||
| 2017-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$159.00K 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$257.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |